Globus Medical Inc (NYSE:GMED) currently has a daily average trading volume of 1.55M but it saw 2261951 shares traded in last market. With a market cap of 8.03B USD, the company’s current market price of $59.28 came falling about -3.77 while comparing to the previous closing price of $61.60. In past 52 weeks, the stock remained buoying in the range of price level as high as $94.93 and as low as $54.48.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BofA Securities which upgraded the stock as “Neutral” in its note to investors issued on January 10, 2025, recommending a price target of $97 for it. Morgan Stanley upgraded its recommendation for the stock as a “Overweight” from “Equal-Weight” on December 02, 2024 while assigning a price target range of $83-$100. Wells Fargo also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $60 and $78.
Over the week, GMED’s stock price is moving 1.91% up while it is -15.39% when we observe its performance for the past one month. Year-to-date it is -28.33% down and over the past year, the stock is showing a downside performance of -7.95%.
Currently, Globus Medical Inc’s total number of outstanding shares is 112.93M with 0.69% of that held by the insiders while 101.04% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 4.45% and return on equity (ROE) at 4.63%. It has a price to earnings ratio (P/E ratio) of 44.34 while having a 15.91 of forward P/E ratio. Stock’s beta reads 1.23. Stock has a price to book (P/B) ratio of 1.96 while price to sale or P/S ratio amounts to 3.20. Its return on asset (ROA) is 3.84% on average.
